Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer

Emiliano Cocco,Stefania Bellone,Karim El-Sahwi,Marilisa Cargnelutti,Francesca Casagrande,Natalia Buza,Fattaneh A. Tavassoli,Siegel Er,Irene Visintin,Elena Ratner,Dan-Arin Silasi,Masoud Azodi,Schwartz Pe,Thomas J. Rutherford,Sergio Pecorelli,Alessandro D. Santin

Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer

2009

Emiliano Cocco
Stefania Bellone
Karim El-Sahwi
Marilisa Cargnelutti
Francesca Casagrande
Natalia Buza
Fattaneh A. Tavassoli
Siegel Er
Irene Visintin
Elena Ratner
Dan-Arin Silasi
Masoud Azodi
Schwartz Pe
Thomas J. Rutherford
Sergio Pecorelli
Alessandro D. Santin

Background: Uterine serous papillary carcinoma (USPC) is a biologically aggressive variant of endometrial cancer. We investigated the expression of Serum Amyloid A (SAA) and evaluated its potential as a serum biomarker in USPC patients.

Keywords:

Carcinoma
Serum amyloid A
Cancer
Uterine Neoplasm
Pathology
Serum Amyloid A Protein
Medicine
Serous fluid
Endometrial cancer
Biomarker (medicine)
Flow cytometry
Immunohistochemistry

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations